NV GXL LINER LIPPED 40MM ID, GROUP 3 CUPS
Report
- Report Number
- 1038671-2024-01254
- Event Type
- Injury
- Date Received
- May 15, 2024
- Date of Event
- April 29, 2024
- Report Date
- February 25, 2025
- Manufacturer
- EXACTECH, INC.
- Product Code
- JDI
- UDI-DI
- 10885862207043
- PMA / PMN Number
- K121392
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
PENDING INVESTIGATION. D10: 4789622 188-01-07 - WEDGE PLASMA X/O SZ 7. 4859112 186-01-56 - INTEGRIP CC, CLUSTER 56MM,G3 . 4893051 170-40-03 - BIOLOX DELTA FEMORAL HEAD 40MM 0D, +3.5MM 4912710 180-65-30 - ALTEON 6.5MM SCREW, 30MM.
BASED ON THE AVAILABLE INFORMATION, THE PATIENT MEETS THE FOLLOWING RISK CRITERIA FOR EARLY PROSTHESIS WEAR AND/OR OSTEOLYSIS: IMPLANTED WITH A LATERALIZED LINER, COMBINATION OF LARGEST AVAILABLE FEMORAL HEAD AND/OR THINNEST AVAILABLE ACETABULAR LINER WAS USED AND IMPLANTED WITH A COMPONENT HAVING A SHELF AGE OF GREATER THAN 2 YEARS. THE MOST LIKELY CAUSE FOR THE REPORTED REVISION DUE TO PROSTHESIS WEAR AND OSTEOLYSIS MAY HAVE BEEN A COMBINATION OF RISK FACTORS SUCH AS USE ERROR, IMPLANT POSITIONING, IMPLANT SIZE SELECTION, AND PATIENT FACTORS (FITNESS FOR SURGERY, BIOMECHANICS, ACTIVITY LEVEL AND LOCAL TISSUE OXIDATION POTENTIAL). HOWEVER, THIS CANNOT BE CONFIRMED AS THE DEVICES WERE NOT RETURNED FOR EVALUATION, AND IMAGES AND RADIOGRAPHS WERE NOT PROVIDED. H6: CORRECTED HEALTH EFFECT, MEDICAL DEVICE, COMPONENT, AND INVESTIGATION CLINICAL CODES.
AS REPORTED, APPROXIMATELY 6 YEARS 9 MONTHS POST THE INITIAL THA, THE PATIENT WAS REVISED DUE TO SEVERE OSTEOLYSIS AND POLY WEAR. THE POLY WAS IN SEVERAL PIECES. NO ISSUES WITH SURGERY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1357633 | NV GXL LINER LIPPED 40MM ID, GROUP 3 CUPS | PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED | JDI | EXACTECH, INC. | 10885862207043 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Required Intervention | SEE H10. |